Generic Manufacturers Find Their New Medicine | Morningstar
Drugmakers Delving Into Multiple Sclerosis Market | Morningstar
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva: Generic drug giant stumbles into NJ with $40M tax break from you
3 Warren Buffett Stocks on Sale | Morningstar
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva to buy Barr for $7.46 billion, boost generic lead | Reuters
Teva Shares Undervalued Despite Opioid Case | Morningstar
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Morningstar Advisor - April/May 2010 - 63
Teva Pharmaceuticals USA - ZIP 45213, NAICS 523930
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Morningstar Investment Services LLC ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
TEVA Institutional Ownership - Teva Pharmaceutical Industries Ltd. Stock
3 Undervalued Warren Buffett Stocks | Morningstar
Shield Therapeutics PLC to continue “robust” defence of IP as Teva Pharmaceutical Industries Ltd appeals Feraccru ruling
The Hemophilia Market - Morningstar
Teva Pharmaceutical Industries Is Turning A Corner (NYSE:TEVA) | Seeking Alpha
Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suit | Reuters
Morningstar Advisor - June/July 2012 - 46
